期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 56, 期 9, 页码 4838-4844出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00983-12
关键词
-
资金
- Today's and Tomorrow's Children's Fund
- UCLA Department of Pediatrics Nanopediatrics Program
No antiviral drugs currently exist for the treatment of enterovirus infections, which are often severe and potentially life threatening. Molecular screening of small molecule libraries identified fluoxetine, a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication. Fluoxetine did not interfere with either viral entry or translation of the viral genome. Instead, fluoxetine and its metabolite norfluoxetine markedly reduced the synthesis of viral RNA and protein. In view of its favorable pharmacokinetics and safety profile, fluoxetine warrants additional study as a potential antiviral agent for enterovirus infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据